About Cefa-Cilinas Biotics
Cefa-Cilinas Biotics is a company based in Aurangabad (India) founded in 2012. It operates as a B2B. Cefa-Cilinas Biotics offers products and services including Amlodipine Base API, Cetirizine Dihydrochloride API, Ibuprofen API, Iodine Derivatives, and Acetophenone Derivatives. Cefa-Cilinas Biotics operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Aurangabad, India
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Cefa-Cilinas Biotics Private Limited
- Date of Incorporation 12 Mar, 2016
- Jurisdiction Aurangabad, Maharashtra, India
-
Annual Revenue
$591.07 K (USD)-14.39as on Mar 31, 2023
-
Net Profit
-$142.66 K (USD)-1758.51as on Mar 31, 2023
-
EBITDA
$2.21 K (USD)-86.27as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cefa-Cilinas Biotics
Cefa-Cilinas Biotics offers a comprehensive portfolio of products and services, including Amlodipine Base API, Cetirizine Dihydrochloride API, Ibuprofen API, Iodine Derivatives, and Acetophenone Derivatives.
Active ingredient used in blood pressure medications for treatment.
Antihistamine compound for allergy relief and symptom management.
Nonsteroidal anti-inflammatory drug for pain and fever reduction.
Chemical compounds used in pharmaceutical and industrial applications.
Intermediates for synthesis in drug and chemical manufacturing processes.
Funding Insights of Cefa-Cilinas Biotics
Detailed funding history for Cefa-Cilinas Biotics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cefa-Cilinas Biotics
Investment portfolio details for Cefa-Cilinas Biotics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cefa-Cilinas Biotics
Detailed financials for Cefa-Cilinas Biotics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cefa-Cilinas Biotics Comparisons
Peer comparison for Cefa-Cilinas Biotics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cefa-Cilinas Biotics
Cefa-Cilinas Biotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Cefa-Cilinas Biotics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cefa-Cilinas Biotics
Complete news archive for Cefa-Cilinas Biotics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cefa-Cilinas Biotics
Cefa-Cilinas Biotics was founded in 2012.
Cefa-Cilinas Biotics is headquartered in Aurangabad, India. It is registered at Aurangabad, Maharashtra, India.
Annual revenue of Cefa-Cilinas Biotics is $591.07K as on Mar 31, 2023.
Cefa-Cilinas Biotics Pvt. Ltd., based in Aurangabad, India, specializes in producing pharmaceutical active ingredients and intermediates such as Amlodipine and Cetirizine APIs. The company focuses on high-quality manufacturing of chemicals, including iodine and acetophenone derivatives, adhering to industry standards. They export products like specialty chemicals and agro ingredients to global clients, emphasizing effective quality control and customer service.
Cefa-Cilinas Biotics's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Cefa-Cilinas Biotics offers Amlodipine Base API, Cetirizine Dihydrochloride API, Ibuprofen API, Iodine Derivatives, and Acetophenone Derivatives.